Pfizer is having ongoing discussions with regulatory agencies for a booster dose of its COVID-19 vaccine and is potentially submitting an emergency use authorization application for the additional vaccine as early as August.
Pfizer is having ongoing discussions with regulatory agencies for a booster dose of its COVID-19 vaccine and is potentially submitting an emergency use authorization application for the additional vaccine as early as August.